Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Metynodiol diacetate
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | Metynodiol diacetate; SC-19198; 11β-Methyletynodiol diacetate; 11β-Methyl-19-norpregn-4-en-20-yne-3β,17α-diyl diacetate; 11β-Methyl-17α-ethynylestr-4-ene-3β,17β-diol diacetate |
Drug class | Progestogen; Progestogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H34O4 |
Molar mass | 398.543 g·mol−1 |
3D model (JSmol) | |
| |
|
Methynodiol diacetate (USAN) (developmental code name SC-19198), or metynodiol diacetate, also known as 11β-methyletynodiol diacetate, is a steroidal progestin of the 19-nortestosterone group which was patented in 1968 but was never marketed. It is the diacetate ester of metynodiol, which, similarly, was never marketed.